©The Author(s) 2025.
World J Orthop. Nov 18, 2025; 16(11): 110420
Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.110420
Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.110420
Table 3 Bivariate analysis concerning the diagnosis of fragility fractures
| Variable | Fracture (n = 27) | No fracture (n = 97) | P value |
| Age (years), mean ± SD | 56 ± 18.3 | 55 ± 14.4 | 0.7519 |
| Time of evolution (years), mean ± SD | 12 ± 10.8 | 11.9 ± 8.7 | 0.9951 |
| Body mass index (kg/m2), mean ± SD | 26 ± 4.4 | 27 ± 4.4 | 0.5083 |
| IGF-1 (mean, IC) | 429 (224 to 1072) | 454 (173 to 1977) | 0.9241 |
| Lanreotide or octreotide, n (%) | 14 (52) | 60 (62) | 0.712 |
- Citation: Alvarez M, Rincon J, Ulloa MM, Rincon O, Mejia L, Alvarado A, Pereira A, Bernal M. Osteoporosis and fragility fractures in patients with acromegaly: A two-center cross-sectional study. World J Orthop 2025; 16(11): 110420
- URL: https://www.wjgnet.com/2218-5836/full/v16/i11/110420.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i11.110420